Advocacy Article Clinical Trials Sleep 
MMJ Recs
JULY 9, 2024
In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients. More rigorous clinical trials are needed to establish clear guidelines for its use in MS management.
MMJ Recs
NOVEMBER 30, 2023
In this comprehensive article, we’ll delve into the potential benefits and challenges of using MMJ as a treatment for epilepsy, as well as share the perspectives of both medical professionals and patients who have experienced the promising effects of MMJ on seizure control and overall well-being.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 24, 2021
Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Conclusions. Background.
SMPL
MAY 26, 2020
And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. Read the full article here. But the research wasn’t enough.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Drug Science. Matthew Johnson. Johns Hopkins University.
Expert insights. Personalized for you.
111 
Let's personalize your content